October 14, 2009 (Baltimore, Maryland) — A new study using data from the National Inpatient Sample, a nationally representative database, shows that although thrombolytic therapy with recombinant ...

The thrombolytic tenecteplase may have a role in reestablishing blood flow in patients with large-vessel acute ischemic stroke up to 24 hours after stroke onset selected by perfusion imaging, a new ...

HONOLULU, HI—Patients with acute ischemic stroke who have salvageable brain tissue identified with advanced imaging appear to benefit from IV tissue plasminogen activator (tPA) beyond ...

Making the switch from alteplase to tenecteplase for stroke thrombolysis can be done successfully when the appropriate preparations are taken, and it may improve patient outcomes, the experience of a ...

Two studies have shown no added benefit of intravenous thrombolysis in patients with acute stroke who are treated with mechanical thrombectomy. We review the importance and interpretation of these ...

Hoffmann-La Roche Limited (Roche Canada) is proud to announce that Health Canada has granted market authorization for TNKase® ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Thrombolytic Science, LLC (TSI) today announced initiation of a Phase 2 clinical trial to confirm the efficacy and safety of its sequential dual-treatment regimen of ...

Comprehensive protocols in emergency departments (EDs) can allow rapid assessment of stroke patients eligible for early-stage treatment, according to a study published in the latest Medical Journal of ...

Intravenous thrombolysis with recombinant tissue plasminogen activator (IV rtPA) is an established and effective treatment for acute ischaemic stroke. 1,2,3 tPA is a serine protease that catalyses the ...

Background: Thrombolysis for acute ischemic stroke has remained controversial. The Canadian Alteplase for Stroke Effectiveness Study, a national prospective cohort study, was conducted to assess the ...

Neurologists around the world are aware that the delivery of thrombolytic treatment for stroke in Helsinki University Hospital, Finland, is freaking fast - but is it too fast? A new study published on ...